Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
16.26
-0.33 (-1.99%)
At close: Oct 10, 2025, 4:00 PM EDT
16.00
-0.26 (-1.60%)
After-hours: Oct 10, 2025, 5:13 PM EDT

Aardvark Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2024
Period Ending
Oct '25 Dec '24 Dec '23
353--
Enterprise Value
211.6253.5333.97
PB Ratio
2.5800
EV/EBITDA Ratio
--2.35-4.58
EV/EBIT Ratio
--2.35-4.58
EV/FCF Ratio
--2.94-5.83
Debt / Equity Ratio
0.000.010.01
Debt / EBITDA Ratio
--0.03-0.02
Debt / FCF Ratio
--0.04-0.03
Quick Ratio
13.7614.957.23
Current Ratio
14.0415.057.50
Return on Equity (ROE)
0.00%-49.63%-52.47%
Return on Assets (ROA)
0.00%-51.76%-70.38%
Return on Capital (ROIC)
0.00%-1142.68%-2648.21%
Return on Capital Employed (ROCE)
0.00%-55.75%-81.00%
Updated Aug 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q